The strength of the PERI Group and its experts ensures that, especially in the most sensitive phases of reimbursement projects, every support is actually available when it is needed. The large number of our projects ensures that we learn early on about trends and developments that may be relevant to our clients.

Comprehensive support also includes the involvement of relevant stakeholders and experts at the medical and political levels. Here, knowledge is generated and shared with selected people from specialist circles.

We make our extensive expertise available for strategic consulting and operational implementation throughout the entire reimbursement process. All documents required in the course of the evaluation process, i.e. pharmacological, medical-therapeutic and economic evaluation, are prepared jointly in close coordination and according to the client’s ideas. Optionally, we also take over the submission and electronic communication with the main association during the entire procedure.

In addition to the reimbursement procedure for approved drugs, we also have broad experience in the reimbursement of products not approved as drugs, such as the award of the S or DS mark or inclusion in the reimbursement catalogue for therapeutic aids and aids.